ApoE controls the interface linking lipids and inflammation in atherosclerosis.
暂无分享,去创建一个
[1] D. Rader,et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. , 2011, The Journal of clinical investigation.
[2] A. Tall,et al. ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.
[3] P. Libby,et al. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.
[4] P. Libby,et al. Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.
[5] T. Simon,et al. Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice , 2008, Circulation.
[6] Daniel J. Rader,et al. Translating molecular discoveries into new therapies for atherosclerosis , 2008, Nature.
[7] E. Pamer,et al. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.
[8] Oliver Soehnlein,et al. Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis , 2010, Circulation.
[9] W. Kannel,et al. Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The Framingham study. , 1966, The New England journal of medicine.
[10] S. Lira,et al. Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2−/− Mice: Evidence for Independent Chemokine Functions in Atherogenesis , 2008, Circulation.
[11] P. Libby,et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.
[12] M. Chiariello,et al. Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction. , 2010, Atherosclerosis.
[13] H. Broxmeyer. Chemokines in hematopoiesis , 2008, Current opinion in hematology.
[14] R. Koenen,et al. Therapeutic targeting of chemokine interactions in atherosclerosis , 2010, Nature Reviews Drug Discovery.
[15] D. Williams,et al. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. , 1991, Journal of immunology.
[16] D. Rader,et al. Novel HDL-directed pharmacotherapeutic strategies , 2011, Nature Reviews Cardiology.
[17] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[18] P. Ducimetiere,et al. Monocyte count: a risk factor for coronary heart disease? , 1993, American journal of epidemiology.
[19] A. Tall,et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. , 2011, The Journal of clinical investigation.
[20] F. Tacke,et al. Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.